FDA authorizes Moderna's coronavirus vaccine for emergency use
The authorization allows the vaccine to be distributed to people 18 or older.
Watch CBS News
The authorization allows the vaccine to be distributed to people 18 or older.
The FDA has issued emergency use authorization for Moderna's COVID-19 vaccine, the second vaccine to be approved in the U.S. The company will now ship out 6 million initial doses of the vaccine. Lana Zak reports.
With the largest land mass of any country in the world, Russia is positioned to benefit from climate change, according to a new report by New York Times Magazine and ProPublica. Abrahm Lustgarten, the author of that report, joins CBSN to explain.
The rollout for Pfizer's COVID-19 vaccination is now in full swing. Health care workers across the country were among the first Americans to receive the shot this week. This comes as deaths and cases continue to spike, with the U.S. recording thousands of new deaths each day. "Face the Nation" moderator Margaret Brennan joins CBSN's Lana Zak to discuss that and more.
While Santa is gearing up for Christmas at Earth's North Pole, angels are getting into the holiday spirit on Mars' south pole.
The FDA could authorize emergency use of Moderna's coronavirus vaccine as early as today, which would make it the second vaccine available in U.S. CBS News' David Begnaud reports on the fight against the growing pandemic, and Dr. Annette Reboli, professor of medicine and dean of the Cooper Medical School of Rowan University, join CBSN to discuss the latest on efforts to roll out the vaccines.
Health care workers across the country are waiting for their hospital to receive the first round of Pfizer's coronavirus vaccine as COVID-19 surges. Meanwhile, the Food and Drug Administration is gearing up to approve emergency-use authorization for Moderna's vaccine. Dr. Kelechi Olejeme joins CBSN AM one day after receiving the Pfizer vaccine. She explained the differences between the two vaccines and how she felt following her inoculation.
President-elect Joe Biden and Dr. Jill Biden will receive their first dose of the vaccine on Monday.
The Food and Drug Administration could approve Moderna's coronavirus vaccine Friday, which means 6 million doses could be shipped around the country as soon as next week. CBS News correspondent David Begnaud and Dr. Bob Lahita, professor at New York Medical College, join CBSN to discuss the nation's worsening crisis and the new vaccine.
White House correspondent Ben Tracy joins "CBS This Morning" to discuss Vice President Mike Pence getting vaccinated on live TV, what message it sends and the other White House officials who are expected to get the vaccine.